期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
羟考酮与舒芬太尼联合咪达唑仑在无痛结肠镜检查中的应用比较 被引量:12
1
作者 赵婉莹 杨晓春 +5 位作者 谢咏秋 杨爱国 侯新冉 贺宏缘 刘欢 郭曲练 《中国内镜杂志》 2020年第8期37-43,共7页
目的比较羟考酮联合咪达唑仑与舒芬太尼联合咪达唑仑在无痛结肠镜检查中的麻醉效果、安全性及副作用。方法选择无痛结肠镜检查患者60例,按随机数字表随机分为两组。年龄18~65岁;体质指数18.5~27.0 kg/m^2;美国麻醉医师协会(ASA)分级Ⅰ~... 目的比较羟考酮联合咪达唑仑与舒芬太尼联合咪达唑仑在无痛结肠镜检查中的麻醉效果、安全性及副作用。方法选择无痛结肠镜检查患者60例,按随机数字表随机分为两组。年龄18~65岁;体质指数18.5~27.0 kg/m^2;美国麻醉医师协会(ASA)分级Ⅰ~Ⅲ级。所有患者在无痛结肠镜检查前5 min静脉注射咪达唑仑0.05 mg/kg。然后O组(羟考酮组)给予0.10 mg/kg羟考酮,S组(舒芬太尼组)给予0.10μg/kg舒芬太尼,操作过程中可根据患者检查配合情况,适当追加丙泊酚静注10~30 mg/次。所有患者均连续监测血氧饱和度、心率以及无创血压。记录药物起效时间、操作时间、复苏时间和出院时间。记录低血压、血氧饱和度降低、恶心和呕吐等不良反应。记录麻醉医师满意度、消化内科医师(操作人员)满意度、术后1周患者满意度。结果两组患者药物起效时间、操作时间、复苏时间、离室时间、低血压、重度缺氧的发生率比较,差异均无统计学意义(P>0.05),S组的丙泊酚追加率明显高于O组(P<0.05),轻度血氧饱和度降低的发生率明显高于O组(P<0.05),消化内科医生满意度低于O组(P<0.05),麻醉医师满意度低于O组(P<0.05)。两组患者满意度比较,差异无统计学意义(P>0.05)。结论羟考酮联合咪达唑仑用于门诊无痛结肠镜检查安全有效,较舒芬太尼联合咪达唑仑术中轻度低氧血症发生率和丙泊酚添加率低。 展开更多
关键词 羟考酮 舒芬太尼 无痛肠镜 镇静
下载PDF
Pregnancy after liver transplantation:Four-year follow-up of the first case in China's Mainland 被引量:1
2
作者 Dong Xia hong-yuan he +6 位作者 Liang Xu Yi Quan Huai-Quan Zuo Lu-Nan Yan Bo Li Yong Zeng Guang-Dong Pan 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第47期7264-7266,共3页
The safety and feasibility of pregnancy following liver transplantation(LT) have been accredited in a series of LT center.The first case in China's Mainland is reported.The follow-up data of a 22-year-old pregnant... The safety and feasibility of pregnancy following liver transplantation(LT) have been accredited in a series of LT center.The first case in China's Mainland is reported.The follow-up data of a 22-year-old pregnant patient with end-stage liver disease undergone orthotopic liver transplantation were analyzed retrospectively.After surgery,the patient was uneventfully recovered and became pregnant 33 mo after LT.The patient was closely monitored and treated with a standard and individualized triple-drug immunosuppressive therapy throughout her pregnancy.Caesarean section was performed in March 18,2004,and a health live-born infant was delivered.After the delivery,a 4-year follow-up period indicated that the patient was satisfactory with her condition and her baby was healthy.Our case shows that a successful pregnancy following LT is possible and safe in women with end-stage liver diseases under close monitoring.Three factors including mother,baby,and transplanted liver function must be considered for the safety of high-risk pregnancies. 展开更多
关键词 PREGNANCY Liver transplantation FOLLOW-UP
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部